Not much new compared to press release
Responses were observed in 2 patients with centralized nervous system mets. That is out of 11 ALK+ patients (no idea how many had brain mets). 3 patients on treatment over 40 weeks.
No idea why out of 35 patients only 18 were ALK positive and only 11 were evaluable. 28% were Crizotinib naive.
Half life is 23 hours. Taking pills with food reduced absorption by 20%.